Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus
A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark)
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session: Multidrug-resistant tuberculosis
Session type: E-poster session
Number: 1591
Disease area: Respiratory infections
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark). Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus. 1591
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: